SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-08-006568
Filing Date
2008-10-21
Accepted
2008-10-21 16:24:44
Documents
6
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 BIOGEN IDEC, INC. b72570bie10vq.htm 10-Q 771874
2 EX-3.1 SECOND AMENDED AND RESTATED BYLAWS b72570biexv3w1.htm EX-3.1 139741
3 EX-10.1 ANNUAL REATAINER SUMMARY FOR BOARD OF DIRECTORS b72570biexv10w1.htm EX-10.1 10864
4 EX-31.1 SECTION 302 CERTIFICATION OF CEO b72570biexv31w1.htm EX-31.1 9141
5 EX-31.2 SECTION 302 CERTIFICATION OF CFO b72570biexv31w2.htm EX-31.2 9153
6 EX-32.1 SECTION 906 CERTIFICATION OF CEO & CFO b72570biexv32w1.htm EX-32.1 6627
  Complete submission text file 0000950135-08-006568.txt   948996
Mailing Address 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142 6176792000
BIOGEN IDEC INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19311 | Film No.: 081133617
SIC: 2836 Biological Products, (No Diagnostic Substances)